Cargando…

A candidate protective factor in amyotrophic lateral sclerosis: heterogenous nuclear ribonucleoprotein G

Heterogenous nuclear ribonucleoprotein G is down-regulated in the spinal cord of the Tg(SOD1*G93A)1Gur (TG) amyotrophic lateral sclerosis mouse model. However, most studies have only examined heterogenous nuclear ribonucleoprotein G expression in the amyotrophic lateral sclerosis model and heterogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fang, Chen, Wen-Zhi, Jiang, Shi-Shi, Wang, Xiao-Hua, Xu, Ren-Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075103/ https://www.ncbi.nlm.nih.gov/pubmed/36571358 http://dx.doi.org/10.4103/1673-5374.357916

Ejemplares similares

5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis
por: Jiang, Shi-Shi, et al.
Publicado: (2023)

Considerations on the concept, definition, and diagnosis of amyotrophic lateral sclerosis
por: Xu, Ren-Shi, et al.
Publicado: (2021)

Heterogeneous Nuclear Ribonucleoproteins: Implications in Neurological Diseases
por: Low, Yi-Hua, et al.
Publicado: (2020)

Cortical Thinning and Clinical Heterogeneity in Amyotrophic Lateral Sclerosis
por: Mezzapesa, Domenico Maria, et al.
Publicado: (2013)

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020)

Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B
por: He, Yaowu, et al.
Publicado: (2008)

Small nuclear ribonucleoproteins and heterogeneous nuclear ribonucleoproteins in the amphibian germinal vesicle: loops, spheres, and snurposomes
Publicado: (1991)

Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis
por: Wilson, Meghan E., et al.
Publicado: (2010)

Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
por: Rogers, Mary-Louise, et al.
Publicado: (2023)

Nuclear TAR DNA-binding protein 43: A new target for amyotrophic lateral sclerosis treatment
por: Zheng, Mei, et al.
Publicado: (2013)

Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus
por: Shi, Stephanie T., et al.
Publicado: (2000)

Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
por: Deng, Zhiqiang, et al.
Publicado: (2017)

Functions of Heterogeneous Nuclear Ribonucleoproteins in Stem Cell Potency and Differentiation
por: Chen, Qishan, et al.
Publicado: (2013)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Repetitive Nerve Stimulation in Amyotrophic Lateral Sclerosis
por: Sun, Xiao-Sun, et al.
Publicado: (2018)

Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape
por: Sudhakaran, Meenakshi, et al.
Publicado: (2023)

Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?
por: Cipollina, Giada, et al.
Publicado: (2020)

Risk factors for amyotrophic lateral sclerosis
por: Ingre, Caroline, et al.
Publicado: (2015)

Phosphoinositide-3-kinase regulatory subunit 4 participates in the occurrence and development of amyotrophic lateral sclerosis by regulating autophagy
por: Liu, Yue, et al.
Publicado: (2021)

Gene Therapy in Amyotrophic Lateral Sclerosis
por: Fang, Ton, et al.
Publicado: (2022)

Nuclear Phospho-SOD1 Protects DNA from Oxidative Stress Damage in Amyotrophic Lateral Sclerosis
por: Bordoni, Matteo, et al.
Publicado: (2019)

Liquid biopsy: a new source of candidate biomarkers in amyotrophic lateral sclerosis
por: Mendioroz, Maite, et al.
Publicado: (2018)

Genotype-phenotype correlations of amyotrophic lateral sclerosis
por: Li, Hong-Fu, et al.
Publicado: (2016)

Neuromuscular Junction Protection for the Potential Treatment of Amyotrophic Lateral Sclerosis
por: Krakora, Dan, et al.
Publicado: (2012)

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?
por: Hollinger, Sabrina K., et al.
Publicado: (2016)

Heterogeneous Nuclear Ribonucleoproteins Involved in the Functioning of Telomeres in Malignant Cells
por: Shishkin, Sergey S., et al.
Publicado: (2019)

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway
por: Iwabuchi, Erina, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis
por: Wang, G.Y., et al.
Publicado: (2020)

Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
por: Oliveira, Danyllo, et al.
Publicado: (2021)

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
por: Tan, Rachel H., et al.
Publicado: (2023)

Trends in global amyotrophic lateral sclerosis research from 2000 to 2022: A bibliometric analysis
por: Shi, Guanzhong, et al.
Publicado: (2022)

Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis
por: Ingre, Caroline, et al.
Publicado: (2020)

Workplace Exposures and the Risk of Amyotrophic Lateral Sclerosis
por: Fang, Fang, et al.
Publicado: (2009)

MRI Volumetric Analysis of the Thalamus and Hypothalamus in Amyotrophic Lateral Sclerosis
por: Ye, Shan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k2gh9teh31he7ctdm9jj3gti3q